Literature DB >> 26922062

Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.

Vignesh Shanmugam1, Elizabeth Margolskee2, Michael Kluk2, Tamara Giorgadze2, Attilio Orazi2.   

Abstract

Rosai-Dorfman disease (RDD) or sinus histiocytosis with massive lymphadenopathy is a rare histiocytic proliferation that is generally considered to be reactive with a benign clinical course. The etiology of RDD is very poorly understood. Recent studies have shown frequent BRAF, NRAS, KRAS, and PIK3CA activating mutations in several histiocytic neoplasms highlighting the emerging importance of the RAF/MEK/ERK pathway in the pathogenesis of these diseases. Here we report a case of Rosai-Dorfman disease involving the submandibular salivary gland with a KRAS K117N missense mutation discovered by next-generation sequencing. These results suggest that at least a subset of RDD cases may be clonal processes. Further mutational studies on this rare histiocytic disease should be undertaken to better characterize its pathogenesis as well as open up potential avenues for therapy.

Entities:  

Keywords:  Clonality; Histiocytosis; Next generation sequencing; Pathogenesis; Rosai–Dorfman disease; Sinus histiocytosis with massive lymphadenopathy

Mesh:

Substances:

Year:  2016        PMID: 26922062      PMCID: PMC4972763          DOI: 10.1007/s12105-016-0709-6

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  41 in total

Review 1.  Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses.

Authors:  Sheila Weitzman; Ronald Jaffe
Journal:  Pediatr Blood Cancer       Date:  2005-09       Impact factor: 3.167

2.  Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.

Authors:  Jean-François Emile; Eli L Diamond; Zofia Hélias-Rodzewicz; Fleur Cohen-Aubart; Frédéric Charlotte; David M Hyman; Eunhee Kim; Raajit Rampal; Minal Patel; Chezi Ganzel; Shlomzion Aumann; Gladwys Faucher; Catherine Le Gall; Karen Leroy; Magali Colombat; Jean-Emmanuel Kahn; Salim Trad; Philippe Nizard; Jean Donadieu; Valérie Taly; Zahir Amoura; Omar Abdel-Wahab; Julien Haroche
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

3.  Co-existent Langerhans cell histiocytosis and Rosai-Dorfman disease: a diagnostic rarity.

Authors:  R Sachdev; J Shyama
Journal:  Cytopathology       Date:  2007-03-27       Impact factor: 2.073

4.  Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement.

Authors:  Elisabeth Dion; Claire Graef; Anne Miquel; Julien Haroche; Bertrand Wechsler; Zahir Amoura; Delphine Zeitoun; Philippe A Grenier; Jean-Claude Piette; Jean-Denis Laredo
Journal:  Radiology       Date:  2005-12-21       Impact factor: 11.105

5.  Rosai-Dorfman disease presenting as a parotid mass.

Authors:  L Norman; A C Bateman; G W Watters; V Singh; A V Spedding
Journal:  J Laryngol Otol       Date:  1997-11       Impact factor: 1.469

6.  Rosai-Dorfman disease of the parotid gland: cytologic and histopathologic findings with immunohistochemical correlation.

Authors:  R Juskevicius; J L Finley
Journal:  Arch Pathol Lab Med       Date:  2001-10       Impact factor: 5.534

Review 7.  Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases.

Authors:  Stacy L Pineles; Grant T Liu; Xenia Acebes; Jorge Arruga; Sunita Nasta; Ruchira Glaser; Michelle Pramick; Franz Fogt; Peter Le Roux; Roberta E Gausas
Journal:  J Neuroophthalmol       Date:  2011-09       Impact factor: 3.042

8.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

9.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

10.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

View more
  17 in total

Review 1.  Imaging of Histiocytosis in the Era of Genomic Medicine.

Authors:  Hyesun Park; Mizuki Nishino; Jason L Hornick; Eric D Jacobsen
Journal:  Radiographics       Date:  2018-11-30       Impact factor: 5.333

2.  Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.

Authors:  Sofia Garces; L Jeffrey Medeiros; Keyur P Patel; Shaoying Li; Sergio Pina-Oviedo; Jingyi Li; Juan C Garces; Joseph D Khoury; C Cameron Yin
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 3.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

Review 4.  [Non-neoplastic lesions of the mediastinum].

Authors:  A Tzankov
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

Review 5.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

6.  Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Authors:  Fabio Facchetti; Stefano Aldo Pileri; Luisa Lorenzi; Valentina Tabanelli; Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-07-10       Impact factor: 4.064

7.  Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up.

Authors:  Sonia Mahajan; Reiko Nakajima; Mariko Yabe; Ahmet Dogan; Gary A Ulaner; Joachim Yahalom; Ariela Noy; Eli L Diamond; Heiko Schöder
Journal:  Clin Nucl Med       Date:  2020-06       Impact factor: 7.794

Review 8.  MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

Authors:  Rikhia Chakraborty; Omar Abdel-Wahab; Benjamin H Durham
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915

9.  NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.

Authors:  Kuan-Jou Wu; Shu-Hao Li; Jia-Bin Liao; Chien-Chun Chiou; Chieh-Shan Wu; Chien-Chin Chen
Journal:  Biology (Basel)       Date:  2021-05-02

10.  [Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases].

Authors:  W J Fu; J Du; J Lu; L Z Wang; J M Yang; M X He; X X Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.